Codexis, Inc. (LON:0I0X)
London · Delayed Price · Currency is GBP · Price in USD 1.130
-0.080 (-6.58%)
Feb 12, 2026, 3:58 PM GMT
Codexis Market Cap
Codexis has a market cap or net worth of 78.78 million as of February 12, 2026. Its market cap has decreased by -73.08% in one year.
Market Cap
78.78M
Enterprise Value
86.05M
Revenue
39.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.13
Market Cap Chart
Since April 22, 2010, Codexis's market cap has decreased from 293.05M to 78.78M, a decrease of -73.12%. That is a compound annual growth rate of -7.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 78.24M | -28.47% |
| Dec 31, 2025 | 109.39M | -64.72% |
| Dec 31, 2024 | 310.06M | 85.43% |
| Dec 29, 2023 | 167.21M | -34.18% |
| Dec 30, 2022 | 254.05M | -83.04% |
| Dec 31, 2021 | 1.50B | 47.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 191.04M |
| Scancell Holdings | 133.61M |
| Bioventix | 90.13M |
| 4basebio | 86.67M |
| Hemogenyx Pharmaceuticals | 55.28M |
| SkinBioTherapeutics | 51.78M |
| hVIVO | 41.16M |
| Ondine Biomedical | 39.98M |